JP2023541443A5 - - Google Patents

Info

Publication number
JP2023541443A5
JP2023541443A5 JP2023516689A JP2023516689A JP2023541443A5 JP 2023541443 A5 JP2023541443 A5 JP 2023541443A5 JP 2023516689 A JP2023516689 A JP 2023516689A JP 2023516689 A JP2023516689 A JP 2023516689A JP 2023541443 A5 JP2023541443 A5 JP 2023541443A5
Authority
JP
Japan
Prior art keywords
gjb2
nucleic acid
optionally
cells
isolated nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023516689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023541443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/050205 external-priority patent/WO2022056444A1/en
Publication of JP2023541443A publication Critical patent/JP2023541443A/ja
Publication of JP2023541443A5 publication Critical patent/JP2023541443A5/ja
Pending legal-status Critical Current

Links

JP2023516689A 2020-09-14 2021-09-14 GJB2をコードする組換えアデノ随伴ウイルス(rAAV)およびその使用。 Pending JP2023541443A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063078233P 2020-09-14 2020-09-14
US63/078,233 2020-09-14
US202163161619P 2021-03-16 2021-03-16
US63/161,619 2021-03-16
PCT/US2021/050205 WO2022056444A1 (en) 2020-09-14 2021-09-14 Recombinant adeno associated virus (raav) encoding gjb2 and uses thereof

Publications (2)

Publication Number Publication Date
JP2023541443A JP2023541443A (ja) 2023-10-02
JP2023541443A5 true JP2023541443A5 (cg-RX-API-DMAC7.html) 2024-09-26

Family

ID=80631939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023516689A Pending JP2023541443A (ja) 2020-09-14 2021-09-14 GJB2をコードする組換えアデノ随伴ウイルス(rAAV)およびその使用。

Country Status (10)

Country Link
EP (1) EP4211151A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023541443A (cg-RX-API-DMAC7.html)
KR (1) KR20230069157A (cg-RX-API-DMAC7.html)
AU (1) AU2021339843A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023004605A2 (cg-RX-API-DMAC7.html)
CA (1) CA3191533A1 (cg-RX-API-DMAC7.html)
IL (1) IL301057A (cg-RX-API-DMAC7.html)
MX (1) MX2023002978A (cg-RX-API-DMAC7.html)
TW (1) TW202227476A (cg-RX-API-DMAC7.html)
WO (1) WO2022056444A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7713130B2 (ja) * 2019-09-30 2025-07-25 イーライ リリー アンド カンパニー 遺伝性難聴の処置のためのアデノ随伴ウイルス(aav)システム
WO2024011224A2 (en) * 2022-07-08 2024-01-11 The Trustees Of Columbia University In The City Of New York Regulatory element for cell type specific expression of genes in spinal motor neurons
EP4698555A1 (en) * 2023-04-18 2026-02-25 uniQure biopharma B.V. Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs
EP4713463A1 (en) * 2023-05-18 2026-03-25 Decibel Therapeutics, Inc. Compositions and methods for treating gjb2-related hearing loss

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1308458A1 (en) * 2001-10-30 2003-05-07 GenOdyssee New polynucleotides and polypeptides of the CX26 gene
WO2006009870A2 (en) * 2004-06-17 2006-01-26 Epigenomics Ag Compositions and methods for preventing carry-over contamination in nucleic acid amplification reactions
CN101389769A (zh) * 2005-12-28 2009-03-18 森托科尔公司 用于评价和治疗银屑病及相关疾病的标记与方法
WO2019200016A1 (en) * 2018-04-10 2019-10-17 President And Fellows Of Harvard College Aav vectors encoding clarin-1 or gjb2 and uses thereof
US12534739B2 (en) * 2018-10-11 2026-01-27 Decibel Therapeutics, Inc. AAV1 vectors and uses thereof for treatment of otic indications
CN113853437A (zh) * 2018-11-07 2021-12-28 阿库斯股份有限公司 腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途
JP7713130B2 (ja) * 2019-09-30 2025-07-25 イーライ リリー アンド カンパニー 遺伝性難聴の処置のためのアデノ随伴ウイルス(aav)システム
CN116096900A (zh) * 2020-05-13 2023-05-09 阿库斯股份有限公司 用于治疗gjb2相关听力损失的组合物和方法
MX2023013394A (es) * 2021-05-13 2023-12-14 Akouos Inc Composiciones de suministro de terapia genica y metodos para tratar perdida auditiva.

Similar Documents

Publication Publication Date Title
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2022508182A5 (cg-RX-API-DMAC7.html)
CN109715650B (zh) 新颖腺相关病毒衣壳蛋白
US6936466B2 (en) Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors
CN110606874B (zh) 用于基因转移到细胞、器官和组织中的变异aav和组合物、方法及用途
JP2021106619A5 (cg-RX-API-DMAC7.html)
CN102199626B (zh) 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
JP2022549380A5 (cg-RX-API-DMAC7.html)
TW202005978A (zh) 新穎肝靶向腺相關病毒載體
IL259595B2 (en) Scalable methods for producing recombinant adeno-associated viral (aav) vector in serum-free suspension cell culture system suitable for clinical use
JP2007507223A5 (cg-RX-API-DMAC7.html)
JP2022524434A5 (cg-RX-API-DMAC7.html)
WO2016179644A1 (en) Promoters for expression of heterologous genes
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2022525302A5 (cg-RX-API-DMAC7.html)
CN111876432B (zh) 一组肝靶向新型腺相关病毒的获得及其应用
JP2024508696A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2023524024A5 (cg-RX-API-DMAC7.html)
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
CN110770344B (zh) shRNA表达框、携带其的多核苷酸序列及其应用
US20220242917A1 (en) Compositions and methods for producing adeno-associated viral vectors
JP2025513785A5 (cg-RX-API-DMAC7.html)
WO2024050547A2 (en) Compact bidirectional promoters for gene expression
JP2022527126A5 (cg-RX-API-DMAC7.html)